Size Progression of Macular Degeneration After Cataract Surgery

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery

Status and phase: Completed; Phase 4

Conditions: Age-Related Macular Degeneration

Treatments: Procedure: Cataract Surgery

Study type: Interventional

Funder types: Other

Identifiers

NCT01165801

EKAM-1-2061

Details and patient eligibility

About

The purpose of this study was to find out if in patients with non-exudative age-related macular degeneration (AMD), randomly assigned to cataract surgery, any AMD size progression or progression to exudative AMD could be detected 6 months after surgery.

Enrollment: 54 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients with cataract and non-exudative age-related macular degeneration

Exclusion criteria

• Patients with retinal pathologies other than AMD, exudative AMD, progressive glaucoma, myopia > 10 diopters, panretinal laser treatment, former cataract or vitreoretinal surgery, were excluded.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

54 participants in 1 patient group

Control Group (CO)

No Intervention group

Description:

Fifty-four patients with cataract and non-exudative age-related macular degeneration (AMD) were randomized into an early surgery group (ES=28) with immediate cataract surgery and a control group (CO=26) where surgery was performed after six months.

Treatment:

Procedure: Cataract Surgery